Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1244891.RATtotH2XvEQILRn4Re4HFLyEjHEuGewysbttkSC_HD5g130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1244891.RATtotH2XvEQILRn4Re4HFLyEjHEuGewysbttkSC_HD5g130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1244891.RATtotH2XvEQILRn4Re4HFLyEjHEuGewysbttkSC_HD5g130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1244891.RATtotH2XvEQILRn4Re4HFLyEjHEuGewysbttkSC_HD5g130_provenance.
- NP1244891.RATtotH2XvEQILRn4Re4HFLyEjHEuGewysbttkSC_HD5g130_assertion description "[Three DNA-based homologous recombination deficiency (HRD) scores (HRD-loss of heterozygosity score (LOH), HRD-telomeric allelic imbalance score (TAI), and HRD-large-scale state transition score (LST)) have been developed that are highly correlated with defects in BRCA1/2, and are associated with response to platinum therapy in triple negative breast and ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244891.RATtotH2XvEQILRn4Re4HFLyEjHEuGewysbttkSC_HD5g130_provenance.
- NP1244891.RATtotH2XvEQILRn4Re4HFLyEjHEuGewysbttkSC_HD5g130_assertion evidence source_evidence_literature NP1244891.RATtotH2XvEQILRn4Re4HFLyEjHEuGewysbttkSC_HD5g130_provenance.
- NP1244891.RATtotH2XvEQILRn4Re4HFLyEjHEuGewysbttkSC_HD5g130_assertion SIO_000772 25475740 NP1244891.RATtotH2XvEQILRn4Re4HFLyEjHEuGewysbttkSC_HD5g130_provenance.
- NP1244891.RATtotH2XvEQILRn4Re4HFLyEjHEuGewysbttkSC_HD5g130_assertion wasDerivedFrom befree-2016 NP1244891.RATtotH2XvEQILRn4Re4HFLyEjHEuGewysbttkSC_HD5g130_provenance.
- NP1244891.RATtotH2XvEQILRn4Re4HFLyEjHEuGewysbttkSC_HD5g130_assertion wasGeneratedBy ECO_0000203 NP1244891.RATtotH2XvEQILRn4Re4HFLyEjHEuGewysbttkSC_HD5g130_provenance.
- befree-2016 importedOn "2016-02-19" NP1244891.RATtotH2XvEQILRn4Re4HFLyEjHEuGewysbttkSC_HD5g130_provenance.